Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS
Y Mei1, B Zhao1, A A Basiorka2
1Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Abstract:
Anemia is characteristic of myelodysplastic syndromes (MDS). The mechanisms of anemia in MDS are unclear. Using a mouse genetic approach, here we show that dual deficiency of mDia1 and miR-146a, encoded on chromosome 5q and commonly deleted in MDS (del(5q) MDS), causes an age-related anemia and ineffective erythropoiesis mimicking human MDS. We demonstrate that the ageing bone marrow microenvironment is important for the development of ineffective erythropoiesis in these mice. Damage-associated molecular pattern molecules (DAMPs), whose levels increase in ageing bone marrow, induced TNFα and IL-6 upregulation in myeloid-derived suppressor cells (MDSCs) in mDia1/miR-146a double knockout mice. Mechanistically, we reveal that pathologic levels of TNFα and IL-6 inhibit erythroid colony formation and differentially affect terminal erythropoiesis through reactive oxygen species-induced caspase-3 activation and apoptosis. Treatment of the mDia1/miR-146a double knockout mice with all-trans retinoic acid, which promoted the differentiation of MDSCs and ameliorated the inflammatory bone marrow microenvironment, significantly rescued anemia and ineffective erythropoiesis. Our study underscores the dual roles of the ageing microenvironment and genetic abnormalities in the pathogenesis of ineffective erythropoiesis in del(5q) MDS.
Insights
Dual deficiency of mDia1 and miR-146a in mice causes anemia mimicking myelodysplastic syndromes (MDS). Ageing bone marrow and inflammation contribute to ineffective erythropoiesis, which was reversed by all-trans retinoic acid treatment.
Area of Science:
- Hematology
- Genetics
- Immunology
Background:
- Anemia is a hallmark of myelodysplastic syndromes (MDS), but its underlying mechanisms remain poorly understood.
- Chromosome 5q deletions are common in MDS, often involving genes like mDia1 and miR-146a.
Purpose of the Study:
- To investigate the role of mDia1 and miR-146a deficiency in MDS pathogenesis.
- To elucidate the mechanisms of anemia and ineffective erythropoiesis in a mouse model.
Main Methods:
- A mouse genetic model with dual deficiency of mDia1 and miR-146a was utilized.
- Age-related bone marrow microenvironment changes and inflammatory responses were analyzed.
- The effects of all-trans retinoic acid on the disease phenotype were evaluated.
Main Results:
- Mice with mDia1/miR-146a deficiency developed age-related anemia and ineffective erythropoiesis, mirroring human del(5q) MDS.
- Ageing bone marrow microenvironment and damage-associated molecular patterns (DAMPs) induced TNFα and IL-6 in myeloid-derived suppressor cells (MDSCs).
- Pathologic TNFα and IL-6 levels inhibited erythroid formation and promoted apoptosis, leading to anemia.
Conclusions:
- Combined genetic abnormalities (mDia1/miR-146a deficiency) and an ageing microenvironment are critical in del(5q) MDS pathogenesis.
- Inflammatory mediators like TNFα and IL-6 play a key role in ineffective erythropoiesis.
- Targeting MDSC differentiation and inflammation, as with all-trans retinoic acid, can ameliorate MDS-related anemia.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythropoiesis
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

